The software is the first of its kind to achieve the FDA's approval for detecting, measuring and grading ARIA on MRI scans—a task that is critical in managing the disease. 

The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.

Ultrasonography-guided nerve blocks have grown in popularity in recent years, but some are hesitant to adopt the procedure. 

A recent comparison of the two modalities’ utility for guiding radiation therapy for prostate cancer shows numerous benefits for MRI over CT.

Women's imaging experts believe the new upgrade could “dramatically improve breast cancer detection.” 

Knowledge of clot composition helps guide clinical management decisions following acute ischemic stroke.

Under the “strategic collaboration,” subsidiary DeepHealth and GE will develop solutions that harness AI to address key challenges in radiology. 

Pylarify is a PSMA-targeted PET agent for pinpointing suspected metastasis or recurrence of prostate cancer, which will be impacted by a new Medicare policy change.